Skip to content

Application of video-assisted thoracoscopic surgery in severe thoracic trauma: a randomized controlled trial.

Application of video-assisted thoracoscopic surgery in severe thoracic trauma

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034150
Enrollment
Unknown
Registered
2020-06-26
Start date
2020-07-15
Completion date
Unknown
Last updated
2020-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest trauma

Interventions

VATS group:VATS exploration, hemostasis, repair and placement of thoracic closed drainage
Simple drainage group:Placement of thoracic closed drainage

Sponsors

Shapingba District People's Hospital of Chongqing
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged between 18 and 65 years (including 18 and 65 years); 2. Patients with traumatic hemothorax diagnosed by imaging; 3. Patients with hemopneumothorax bleeding volume of 500-1000ml (imaging estimation); 4. Patients with stable hemodynamics; 5. Patients whose vital signs (blood pressure, respiration, heart rate) are basically stable; 6. Patients who are able to follow the research program, participate in the study voluntarily and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with cardiovascular injury; 2. Patients with esophageal rupture due to diaphragm rupture with large bronchial rupture; 3. Patients with serious diseases of heart, brain, liver, kidney, blood and other systems; 4. Lactating women or pregnant women; 5. Patients who have poor compliance and are difficult to complete the treatment; 6. Patients with severe immune deficiency; 7. Patients who abuse drugs or drugs; 8. Patients who are participating in other clinical trials; 9. The researchers think that other reasons are not suitable for the subjects of clinical trials.

Design outcomes

Primary

MeasureTime frame
Intraoperative exploration of blood volume (closed drainage is the extraction volume during catheterization);Hemothorax drainage;Drainage time of hemothorax;Postoperative pulmonary function;Secondary thoracotomy rate;The incidence of major complications (empyema, atelectasis, pulmonary infection, coagulative hemothorax, respiratory failure, ventilator use rate) recorded all other adverse events;death rate;

Secondary

MeasureTime frame
Length of stay;Hospitalization expenses;Degree and duration of pain;A survey of perioperative quality of life;Patient satisfaction;Postoperative follow-up: the follow-up time is 2 years, the first 6 months follow-up interval is 2 months, and after 6 months follow-up every half a year for 2 years;

Countries

China

Contacts

Public ContactGou Yajun

Shapingba District People's Hospital of Chongqing

309100645@qq.com+86 15998905328

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026